Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present EVITRADE HEALTH SYS CORP. (OTC: AXHLF).

Full DD Report for AXHLF

You must become a subscriber to view this report.


Recent News from (OTC: AXHLF)

EVITRADE Health Systems Corp Announces Definitive Agreement
EVITRADE Health Systems Corp Announces Definitive Agreement Vancouver, British Columbia (FSCwire) - EVITRADE Health Systems Corp. (CSE:EVA, OTCQB: AXHLF) (the “Company” or “EVITRADE”) is pleased to announce that it has come to terms for a Defin...
Source: FSCwire
Date: April, 27 2018 22:38
EVITRADE Announces Haywood Securities Continuing Financial Advisory Services
EVITRADE Announces Haywood Securities Continuing Financial Advisory Services Vancouver, British Columbia (FSCwire) - EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: AXHLF) (the “Company”) announces that it has signed an advisors’ services agreement (&...
Source: FSCwire
Date: April, 09 2018 19:00
EVITRADE Health Systems Corp Announces LOI
EVITRADE Health Systems Corp Announces LOI Vancouver, British Columbia (FSCwire) - EVITRADE Health Systems Corp. (CSE:EVA, OTCQB: AXHLF) (the “Company” or “EVITRADE”) is pleased to announce that it has signed a Letter of Intent and negotiated t...
Source: FSCwire
Date: March, 06 2018 08:30
EVITRADE Announces LOI to Acquire Artillery Labs
EVITRADE Announces LOI to Acquire Artillery Labs
Source: OTC Markets
Date: March, 06 2018 00:00
EVITRADE Health Systems Announces Closing Details of Financing at $2.25 Million
EVITRADE Health Systems Announces Closing Details of Financing at $2.25 Million Vancouver, British Columbia (FSCwire) - EVITRADE Health Systems Corp. (CSE:EVA, OTCQB: AXHLF) (the “Company” or “EVITRADE”) is pleased to announce that it has close...
Source: FSCwire
Date: December, 22 2017 02:32
Evitrade Announces Closing Details of Financing at $2.25 Million
Evitrade Announces Closing Details of Financing at $2.25 Million
Source: OTC Markets
Date: December, 22 2017 00:00
EVITRADE Health Systems Announces Closing of Financing
EVITRADE Health Systems Announces Closing of Financing Vancouver, British Columbia (FSCwire) - EVITRADE Health Systems Corp. (CSE:EVA, OTCQB: AXHLF) (the “Company” or “EVITRADE”) is pleased to announce that it has closed the financing.  ...
Source: FSCwire
Date: December, 20 2017 09:00
EVITRADE Announces Closing of Financing
EVITRADE Announces Closing of Financing
Source: OTC Markets
Date: December, 20 2017 00:00
EVITRADE Health Systems Announces Upsizing of Financing to $2,500,000 CAD
EVITRADE Health Systems Announces Upsizing of Financing to $2,500,000 CAD Vancouver, British Columbia (FSCwire) - EVITRADE Health Systems Corp. (CSE:EVA, OTCQB: AXHLF) (the “Company” or “EVITRADE”) today announces that due to significant intere...
Source: FSCwire
Date: December, 19 2017 09:00
EVITRADE Health Announces Upsizing Financing to a Maximum $2.5 Million CAD
EVITRADE Health Announces Upsizing Financing to a Maximum $2.5 Million CAD
Source: OTC Markets
Date: December, 19 2017 00:00

 


About EVITRADE HEALTH SYS CORP. (OTC: AXHLF)

Logo for EVITRADE HEALTH SYS CORP. (OTC: AXHLF)

EVITRADE formerly Auxellence Health Corp. is a health technology company engaged in the provision of biomedical online services for common health issues. The company is involved in developing and integrating technologies for a digital healthcare platform for physiologically interactive computing supporting therapeutic diagnostic theranostic devices, expert tele medical systems, cryptographically secured medical records and transmission applications for personal health management.

 

 

 

Current Management

  • Sydney Au / CEO
  • Faisal Manji / CFO
  • Sydney Au / Chairman
  • C.K. Cheung / Independent Director
  • Faisal Manji /
  • Ronald Valdis Ozols / Independent Director, Audit Committee Member

Current Share Structure

  • Market Cap: $10,603,163 - 03/14/2018
  • Issue and Outstanding: 30,390,265 - 12/22/2017

 


Recent Filings from (OTC: AXHLF)

Quarterly Report - Management Discussion and Analysis
Filing Type: Quarterly Report - Management Discussion and AnalysisFiling Source: OTC Markets
Filing Date: January, 28 2018
Quarterly Report - Financial Statements
Filing Type: Quarterly Report - Financial StatementsFiling Source: OTC Markets
Filing Date: January, 28 2018
Officer/Director Disclosure - CFO Certification of Interim Financial Report
Filing Type: Officer/Director Disclosure - CFO Certification of Interim Financial ReportFiling Source: OTC Markets
Filing Date: January, 28 2018
Officer/Director Disclosure - CEO Certification of Interim Financial Report
Filing Type: Officer/Director Disclosure - CEO Certification of Interim Financial ReportFiling Source: OTC Markets
Filing Date: January, 28 2018
Officer/Director Disclosure - CFO Certification for Audited Financial Stmts and MDA June 2017
Filing Type: Officer/Director Disclosure - CFO Certification for Audited Financial Stmts and MDA June 2017Filing Source: OTC Markets
Filing Date: October, 30 2017
Officer/Director Disclosure - CEO Certification for Audited Financial Stmts and MDA June 2017
Filing Type: Officer/Director Disclosure - CEO Certification for Audited Financial Stmts and MDA June 2017Filing Source: OTC Markets
Filing Date: October, 30 2017
Annual Report - Consolidated Report with Amended and Restated 2016 Statements
Filing Type: Annual Report - Consolidated Report with Amended and Restated 2016 StatementsFiling Source: OTC Markets
Filing Date: October, 30 2017
Management Discussion and Analysis - MDA for June 30, 2017 Annual Financial Statments
Filing Type: Management Discussion and Analysis - MDA for June 30, 2017 Annual Financial StatmentsFiling Source: OTC Markets
Filing Date: October, 30 2017
Quarterly Report - EVITRADE Q3 2017 Management Discussion and Analysis to Financial Statements
Filing Type: Quarterly Report - EVITRADE Q3 2017 Management Discussion and Analysis to Financial StatementsFiling Source: OTC Markets
Filing Date: June, 01 2017
Quarterly Report - EVITRADE Q3 2017 FINANCIAL STATEMENTS
Filing Type: Quarterly Report - EVITRADE Q3 2017 FINANCIAL STATEMENTSFiling Source: OTC Markets
Filing Date: June, 01 2017

 

 


Daily Technical Chart for (OTC: AXHLF)

Daily Technical Chart for (OTC: AXHLF)


Stay tuned for daily updates and more on (OTC: AXHLF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: AXHLF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

OTC Report
@OTCReporter

 

 


Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in AXHLF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of AXHLF and does not buy, sell, or trade any shares of AXHLF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: http://otc.report/disclaimer/